Search results
Thousands in one state to lose weight loss drug coverage
Newsweek· 6 days agoThousands of people in Michigan who use popular weight loss drugs will soon lose their coverage for...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 3 days agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
NBC Dallas Fort Worth· 2 days agoMore U.S. employers are covering a buzzy class of medications called GLP-1s for weight loss, a...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity ...
Motley Fool via Yahoo Finance· 6 days agoHowever, it could achieve greater weight loss than Zepbound. Both Lilly and Novo Nordisk have other...
Gateway - Quartz
Quartz· 2 days agoCustomers will be able to get a prescription for the drug from a licensed health care provider directly on the platform. The announcement...GLP-1 medications, the class of ...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
San Jose Mercury News· 5 days agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Scammers make millions selling nonexistent Ozempic, report finds
Newsweek· 6 days agoMcAfee researchers uncovered 449 risky website URLs and 176,871 dangerous email phishing attempts....
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 5 days agoFood and Drug Administration recently unanimously endorsed its approval. Elsewhere, Eli Lilly's...
Subtle victory for Sanders in Novo spat
Politico· 1 day agoA Congressional Budget Office presentation to the American Society of Health Economists noted that spending in the 340B drug discount program grew 19 percent ...
Inside WeightWatchers' shift on Wegovy, Mounjaro, other GLP-1s
Crain s Chicago Business· 2 days agoThe event comes at a time when every discussion about weight loss medications seems to involve glucagon-like peptide agonists. The healthcare industry..
